United Pharm Cash Flow Conversion Efficiency

Latest as of June 2026: 0.028x

United Pharm cash flow conversion efficiency. Based on the latest financial reports, United Pharm (033270) has a cash flow conversion efficiency ratio of 0.028x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩13.70 Billion ≈ $9.28 Million USD) by net assets (₩497.12 Billion ≈ $336.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of United Pharm (2011–2025)

Cash flow conversion efficiency of United Pharm from 2011 to 2025. This chart illustrates how United Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data. View United Pharm (033270) share price today for real-time trading data and today's change.

United Pharm Cash Flow Conversion Ratio Explained

United Pharm cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

United Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of United Pharm ranked by their cash flow conversion efficiency. Also see United Pharm market cap and net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Sun Tekstil Sanayi ve Ticaret A.S. IS:SUNTK	0.091x
Jochu Technology Co Ltd TW:3543	-0.065x
InfuSystems Holdings Inc NYSE MKT:INFU	0.017x
Shangri La Hotels Malaysia Bhd KLSE:5517	0.012x
Oriola-KD Oyj B HE:OKDBV	0.229x
Intermedia Capital Tbk JK:MDIA	0.031x
A Paradise Acquisition Corp. NYSE:APAD	-0.001x
GOCL Corporation Limited NSE:GOCLCORP	-0.008x

Annual Cash Flow Conversion Efficiency for United Pharm (2011–2025)

The table below shows the annual cash flow conversion efficiency of United Pharm from 2011 to 2025. Review 033270 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩454.63 Billion ≈ $308.10 Million	₩51.14 Billion ≈ $34.65 Million	0.112x	+70.52%
2024-12-31	₩406.21 Billion ≈ $275.28 Million	₩26.79 Billion ≈ $18.16 Million	0.066x	-49.81%
2023-12-31	₩378.68 Billion ≈ $256.63 Million	₩49.77 Billion ≈ $33.73 Million	0.131x	-30.38%
2022-12-31	₩337.86 Billion ≈ $228.96 Million	₩63.78 Billion ≈ $43.22 Million	0.189x	+28.77%
2021-12-31	₩300.71 Billion ≈ $203.79 Million	₩44.09 Billion ≈ $29.88 Million	0.147x	+9.82%
2020-12-31	₩276.89 Billion ≈ $187.65 Million	₩36.96 Billion ≈ $25.05 Million	0.133x	-10.75%
2019-12-31	₩255.10 Billion ≈ $172.88 Million	₩38.15 Billion ≈ $25.86 Million	0.150x	-7.30%
2018-12-31	₩228.48 Billion ≈ $154.84 Million	₩36.86 Billion ≈ $24.98 Million	0.161x	+17.54%
2017-12-31	₩201.68 Billion ≈ $136.68 Million	₩27.68 Billion ≈ $18.76 Million	0.137x	-18.90%
2016-12-31	₩177.39 Billion ≈ $120.21 Million	₩30.02 Billion ≈ $20.34 Million	0.169x	+28.50%
2014-12-31	₩161.83 Billion ≈ $109.67 Million	₩21.31 Billion ≈ $14.44 Million	0.132x	-1.80%
2013-12-31	₩141.44 Billion ≈ $95.85 Million	₩18.97 Billion ≈ $12.85 Million	0.134x	-18.19%
2012-12-31	₩133.48 Billion ≈ $90.46 Million	₩21.88 Billion ≈ $14.83 Million	0.164x	-32.90%
2011-12-31	₩113.04 Billion ≈ $76.61 Million	₩27.62 Billion ≈ $18.72 Million	0.244x	--

About United Pharm

KO:033270 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$165.50 Million

₩244.21 Billion KRW

Market Cap Rank

#17102 Global

#670 in Korea

Share Price

₩16910.00

Change (1 day)

+0.36%

52-Week Range

₩16270.00 - ₩21400.00

All Time High

₩95918.11